Institute for Chemical Neuroscience

The Institute for Chemical Neurosciences (iCNS) is a 10-year research program funded by a Gravitation grant from NWO, dedicated to uncovering the molecular mechanisms behind brain diseases and neuropsychiatric symptoms. Mission Psychiatric symptoms like low mood, anxiety, and psychosis occur across psychiatric and neurological syndromes, yet their biological causes remain unknown. Current treatments, including psychotherapy and medication, often lack efficacy and precision. iCNS focuses on molecular and cellular changes in neuronal connections to identify these mechanisms and improve diagnosis and treatment. Innovative Approach Unique Resources: Research uses human brain tissue and donor data from the Netherlands Brain Bank and Netherlands Neurogenetics Database. Cutting-Edge Techniques: Advanced molecular analysis, AI, stem cells, and brain organoids reveal detailed insights into disease processes. Collaborative Network: iCNS unites neurobiologists, chemists, psychiatrists, data scientists, and patient representatives in a multidisciplinary effort to drive breakthroughs. Collaborating Institutions - University of Amsterdam - Amsterdam University Medical Center - Netherlands Institute for Neuroscience - Leiden University - Leiden University Medical Center - Utrecht University - University Medical Center Groningen - Radboud University Medical Center - Erasmus University Medical Center Vision Our research aims to create a "brain atlas" linking molecular changes to psychiatric symptoms, transforming how we understand, diagnose, and treat these disorders. By combining clinical and neuropathological data with advanced analytics, iCNS is driving the future of neuroscience to improve lives worldwide. Stay connected to follow our progress.